JPH02191216A - Drug for fish parasite - Google Patents
Drug for fish parasiteInfo
- Publication number
- JPH02191216A JPH02191216A JP1190712A JP19071289A JPH02191216A JP H02191216 A JPH02191216 A JP H02191216A JP 1190712 A JP1190712 A JP 1190712A JP 19071289 A JP19071289 A JP 19071289A JP H02191216 A JPH02191216 A JP H02191216A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- fish
- compound
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 38
- 244000045947 parasite Species 0.000 title claims abstract description 24
- 239000003814 drug Substances 0.000 title abstract description 11
- 229940079593 drug Drugs 0.000 title description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 13
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 8
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 8
- 125000003118 aryl group Chemical group 0.000 claims abstract description 7
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 6
- 125000004438 haloalkoxy group Chemical group 0.000 claims abstract description 6
- 125000001188 haloalkyl group Chemical group 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- SSPYSWLZOPCOLO-UHFFFAOYSA-N 6-azauracil Chemical class O=C1C=NNC(=O)N1 SSPYSWLZOPCOLO-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 23
- 239000001257 hydrogen Substances 0.000 claims description 22
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 66
- 235000019688 fish Nutrition 0.000 abstract description 38
- 238000011282 treatment Methods 0.000 abstract description 16
- 229910052736 halogen Inorganic materials 0.000 abstract description 10
- 150000002367 halogens Chemical class 0.000 abstract description 10
- 241001465754 Metazoa Species 0.000 abstract description 9
- 230000003071 parasitic effect Effects 0.000 abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 abstract description 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- -1 alkali metal nitride Chemical class 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 18
- 239000000203 mixture Substances 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 150000002431 hydrogen Chemical group 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 239000003085 diluting agent Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 6
- 239000007800 oxidant agent Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241000252233 Cyprinus carpio Species 0.000 description 3
- 241001523601 Gyrodactylus Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241001494191 Myxobolus Species 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Polymers FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- 241001247278 Acanthopagrus schlegelii Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000252087 Anguilla japonica Species 0.000 description 2
- 241000238421 Arthropoda Species 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000239250 Copepoda Species 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 241000011458 Epistylis Species 0.000 description 2
- 241001011968 Hoferellus Species 0.000 description 2
- 241000248482 Ichthyophthirius multifiliis Species 0.000 description 2
- 241000243190 Microsporidia Species 0.000 description 2
- 241001492488 Pleistophora Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000277331 Salmonidae Species 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 125000001164 benzothiazolyl group Chemical class S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- BFGQTWYXWNCTSX-UHFFFAOYSA-N triazine-4,5-dione Chemical class O=C1C=NN=NC1=O BFGQTWYXWNCTSX-UHFFFAOYSA-N 0.000 description 2
- FEOHYDSNGHIXOM-WLDMJGECSA-N (3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)-2-methyloxane-2,4,5-triol Chemical compound CC1(O)[C@H](N)[C@@H](O)[C@H](O)[C@H](O1)CO FEOHYDSNGHIXOM-WLDMJGECSA-N 0.000 description 1
- FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 description 1
- FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical compound C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ICETWLGKJXCIDX-UHFFFAOYSA-N 2,4-dichloro-1,3-thiazole Chemical compound ClC1=CSC(Cl)=N1 ICETWLGKJXCIDX-UHFFFAOYSA-N 0.000 description 1
- ZCSSCCNATAHVMY-UHFFFAOYSA-N 2-(3,5-dichloro-4-hydroxyphenyl)-1,2,4-triazine-3,5-dione Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1N1C(=O)NC(=O)C=N1 ZCSSCCNATAHVMY-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- PLKNGGRZZIWWLD-UHFFFAOYSA-N 3,5-dioxo-2h-1,2,4-triazine-6-carboxylic acid Chemical compound OC(=O)C1=NN=C(O)N=C1O PLKNGGRZZIWWLD-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- IPNSJXMIKIHEKM-UHFFFAOYSA-N 6-(2-hydroxyphenyl)-1H-1,3,5-triazine-2,4-dione Chemical compound OC1=NC(O)=NC(C=2C(=CC=CC=2)O)=N1 IPNSJXMIKIHEKM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241001519451 Abramis brama Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241001204796 Arius maculatus Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 125000006538 C11 alkyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 241001629481 Chilodonella Species 0.000 description 1
- 241001185735 Chilodonella cyprini Species 0.000 description 1
- 241000223782 Ciliophora Species 0.000 description 1
- 241000224483 Coccidia Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241001262815 Dactylogyrus Species 0.000 description 1
- 241000238578 Daphnia Species 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000651059 Hippoglossoides dubius Species 0.000 description 1
- 241000248484 Ichthyophthirius Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241001149911 Isopoda Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 241001502129 Mullus Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241001494190 Myxidium Species 0.000 description 1
- 241001494184 Myxozoa Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000238127 Pagurus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- 241001364006 Plagioscion Species 0.000 description 1
- 241000242594 Platyhelminthes Species 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 241000269980 Pleuronectidae Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000231739 Rutilus rutilus Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000692569 Stylephorus chordatus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241001248640 Thelohania Species 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 241000242541 Trematoda Species 0.000 description 1
- 241001500087 Trichodina Species 0.000 description 1
- 241000545760 Unio Species 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- HSOGVWWWGVFXGF-UHFFFAOYSA-N ethyl n-(2-cyanoacetyl)carbamate Chemical compound CCOC(=O)NC(=O)CC#N HSOGVWWWGVFXGF-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005606 polypropylene copolymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- CUQOHAYJWVTKDE-UHFFFAOYSA-N potassium;butan-1-olate Chemical compound [K+].CCCC[O-] CUQOHAYJWVTKDE-UHFFFAOYSA-N 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000004546 suspension concentrate Substances 0.000 description 1
- 125000000335 thiazolyl group Chemical class 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/707—1,2,3- or 1,2,4-triazines; Hydrogenated 1,2,3- or 1,2,4-triazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2224/00—Indexing scheme for arrangements for connecting or disconnecting semiconductor or solid-state bodies and methods related thereto as covered by H01L24/00
- H01L2224/01—Means for bonding being attached to, or being formed on, the surface to be connected, e.g. chip-to-package, die-attach, "first-level" interconnects; Manufacturing methods related thereto
- H01L2224/42—Wire connectors; Manufacturing methods related thereto
- H01L2224/47—Structure, shape, material or disposition of the wire connectors after the connecting process
- H01L2224/48—Structure, shape, material or disposition of the wire connectors after the connecting process of an individual wire connector
- H01L2224/4805—Shape
- H01L2224/4809—Loop shape
- H01L2224/48091—Arched
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2224/00—Indexing scheme for arrangements for connecting or disconnecting semiconductor or solid-state bodies and methods related thereto as covered by H01L24/00
- H01L2224/01—Means for bonding being attached to, or being formed on, the surface to be connected, e.g. chip-to-package, die-attach, "first-level" interconnects; Manufacturing methods related thereto
- H01L2224/42—Wire connectors; Manufacturing methods related thereto
- H01L2224/47—Structure, shape, material or disposition of the wire connectors after the connecting process
- H01L2224/48—Structure, shape, material or disposition of the wire connectors after the connecting process of an individual wire connector
- H01L2224/481—Disposition
- H01L2224/48151—Connecting between a semiconductor or solid-state body and an item not being a semiconductor or solid-state body, e.g. chip-to-substrate, chip-to-passive
- H01L2224/48221—Connecting between a semiconductor or solid-state body and an item not being a semiconductor or solid-state body, e.g. chip-to-substrate, chip-to-passive the body and the item being stacked
- H01L2224/48245—Connecting between a semiconductor or solid-state body and an item not being a semiconductor or solid-state body, e.g. chip-to-substrate, chip-to-passive the body and the item being stacked the item being metallic
- H01L2224/48247—Connecting between a semiconductor or solid-state body and an item not being a semiconductor or solid-state body, e.g. chip-to-substrate, chip-to-passive the body and the item being stacked the item being metallic connecting the wire to a bond pad of the item
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/15—Details of package parts other than the semiconductor or other solid state devices to be connected
- H01L2924/181—Encapsulation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
【発明の詳細な説明】
本発明は魚類寄生虫、特に寄生性原生動物(単一細胞有
機体)及び後生動物(多細胞有機体)に対する、l、2
.4−トリアジンジオン類を含有する薬剤に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method for treating fish parasites, particularly parasitic protozoa (single-celled organisms) and metazoa (multicellular organisms).
.. The present invention relates to a drug containing 4-triazinediones.
該原生動物及び後生動物は魚類寄生虫として一般的な綱
を包含する。大規模の養魚場での大規模の動物飼育にお
いては、蔓延は全生物に迅速に広がりうるので、該寄生
虫は深刻な問題を提起する。The protozoa and metazoa include common classes of fish parasites. In large-scale animal husbandry in large-scale fish farms, the parasite poses a serious problem as infestations can spread quickly to all organisms.
これらの寄生虫は、飼育特に若く感受性の高い魚の飼育
に大きな問題を提起し、相当の損失を引き起こす。These parasites pose a major problem in the breeding of fish, especially young and susceptible fish, and cause considerable losses.
幾つかの寄生性原生動物及び後生動物は魚の皮及び鱈に
付着し、こうして皮損傷を起こし、細菌、ウィルス、又
はカビの感染を受は易くする。それらはまたウィルス感
染の媒介者でもある。幾つかの寄生性原生動物及び後生
動物は魚の内器官(例えば腸、骨)にも感染し、魚の成
長変形又は死を引き起こす。Some parasitic protozoa and metazoa attach to fish skin and cod, thus causing skin damage and making it susceptible to bacterial, viral, or fungal infections. They are also vectors of viral infection. Some parasitic protozoa and metazoa also infect the internal organs of fish (eg intestines, bones), causing growth deformities or death of the fish.
寄生性原生動物及び後生動物の防除剤としては、僅かし
か知られていない。しかしそれらの作用は必ずしも常に
満足できるものではない。しかもそれらは、ある寄生虫
に対する狭い作用スペクトルを有するに過ぎない。他の
寄生虫、例えばミキソゾア(M yxozoa)又はミ
クロスポリジア(Micr。Few agents are known for controlling parasitic protozoa and metazoa. However, their effects are not always satisfactory. Moreover, they only have a narrow spectrum of action against certain parasites. Other parasites such as Myxozoa or Microsporidia (Micr).
5por id ia)にたいして作用する薬剤は全く
利用できない。No drugs are available that act against 5por id ia).
下記一般式(I)
R1は随時置換されていてもよい芳香族基、又は炭素原
子で結合している随時置換されていてもよい複素芳香族
基を表し;
N
Xはo、s、so、so、又は−CH−を表し;
R1は水素、ハロゲン、ニトロ、アルキル、アルコキシ
、ハロゲノアルキル、ハロゲノアルコキシからなる群か
ら選ばれる、−又はそれ以上の、同−又は異なる基を表
し;R3は水素、随時置換されたアルキル、アルケニル
、アルキニル、アラルキルを表すで表される置換1.2
.4−トリアジンジオン類、及びそれらの塩基による塩
が、魚類寄生虫、特に寄生性原生動物及び後生動物、例
えばプラセルミンテス(P lathelminthe
s)の防除のため使用し得ることが見いだされた。The following general formula (I) R1 represents an optionally substituted aromatic group or an optionally substituted heteroaromatic group bonded to a carbon atom; N X is o, s, so, so, or -CH-; R1 represents - or more, same- or different groups selected from the group consisting of hydrogen, halogen, nitro, alkyl, alkoxy, halogenoalkyl, halogenoalkoxy; R3 is hydrogen , optionally substituted alkyl, alkenyl, alkynyl, aralkyl.
.. 4-triazinediones, and their base salts, are effective against fish parasites, especially parasitic protozoa and metazoa, such as P lathelminthes.
It has been found that it can be used for the control of s).
幾つかのトリアジンジオン類は欧州特許公開明細書(E
P−O3)第170.316号に開示されており、また
それらは本出願人による未公開先願の主題でもある。Some triazinediones are listed in the European Patent Publication Specification (E
P-O3) No. 170.316, and they are also the subject of an unpublished prior application by the applicant.
下記一般式(I)
R1は炭素原子で結合している随時置換されていてもよ
い複素芳香族基を表し;Xはo、s、so、so、を表
し;
R2は水素、ハロゲン、ニトロ、アルキル、アルコキシ
、ハロゲノアルキル、ハロゲノアルコキシからなる群か
ら選ばれる、−又はそれ以上の、同−又は異なる基を表
し;
R3は水素、随時置換されたアルキル、アルケニル、ア
ルキニル、アラルキルを表す
で表される置換1.2.4−トリアジンジオン類は、下
記
a)下記式(n)
式中、XはO又はSを表し;
R2,R3は上記意味を有する
で表される化合物を、下記式(m)
R’−A (I[[)
式中、R1は上記意味を有し;
Aは基:ハロゲン、−o−sow−アルキル、−0−S
O,−ハロゲノアルキル、−0−SO,−アリール、−
5−アルキルを表す
で表される化合物と反応させる;
b)R”が水素を表さない式(I)で表される化合物の
製造は、下記式(Ia)
式中、R’、R”、Xは上記意味を有するで表される化
合物を、下記式(IV)
R3−B (IV)
式中R3は随時置換されたアルキル、アルケニル、アル
キニル、アラルキルを表し;
Bはハロゲン、−0−SO,−アルキル、−0−SO,
−アリール、−0−SO2−ハロゲノアルキルを表す
で表される化合物と反応させる;又は
c)Xが一5O−又は−SO,−を表す式(I)で表さ
れる化合物の製造は、XがSを表す式(I)で表される
化合物と酸化剤とを反応させる;製造方法で製造できる
。The following general formula (I) R1 represents an optionally substituted heteroaromatic group bonded to a carbon atom; X represents o, s, so, so; R2 represents hydrogen, halogen, nitro, R3 represents hydrogen, optionally substituted alkyl, alkenyl, alkynyl, aralkyl; Substituted 1.2.4-triazinediones are represented by the following a) formula (n), where X represents O or S; R2 and R3 have the above meanings; m) R'-A (I[[) where R1 has the above meaning; A is a group: halogen, -o-sow-alkyl, -0-S
O,-halogenoalkyl, -0-SO,-aryl, -
5-alkyl; b) Production of a compound represented by formula (I) in which R" does not represent hydrogen is carried out using the following formula (Ia), where R', R" , X represents a compound represented by the following formula (IV) R3-B (IV) where R3 represents optionally substituted alkyl, alkenyl, alkynyl, aralkyl; B is halogen, -0- SO, -alkyl, -0-SO,
-aryl, -0-SO2-halogenoalkyl; or c) production of a compound of formula (I) in which It can be produced by a production method in which a compound represented by formula (I) in which S represents S is reacted with an oxidizing agent;
下記式(II)
式中、X、R”、R3は上記意味を有するで表される化
合物を過熱して脱カルボキシル化することによって得る
。It is obtained by heating and decarboxylating a compound represented by the following formula (II), where X, R", and R3 have the above meanings.
該式(V)
式中、Xは0又はSを表し;
RJtハロゲン、ニトロ、アルキル、アルコキシ、ハロ
ゲノアルキル、ハロゲノアルコキシからなる群から選ば
れる、−又はそれ以上の、同−又は異なる基を表し、X
がSを表すときは更に水素を表し:
R3は水素、アルキル、アルケニル、アルキニル、アラ
ルキルを表す
で表される化合物は新規であり、下記式(V)式中、X
は0又はSを表し;
R2はハロゲン、ニトロ、アルキル、アルコキシ、ハロ
ゲノアルキル、ハロゲノアルコキシからなる群から選ば
れる、−又はそれ以上の、同−又は異なる基を表し、X
がSを表すときは更に水素を表し;
R3は水素、アルキル、アルケニル、アルキニル、アラ
ルキルを表す
で表される化合物は新規であり、下記式(Vl)式中、
X、R”、R’は(3)で述べた意味を有し;
s
R1は基ニーCN、 −〇〇NC0OR’を表し;
R5は随時置換されたアルキル又はアリールを表す
で表される化合物を、水性酸の存在下、過熱することに
より得る。In the formula (V), X represents 0 or S; RJt represents - or more, same- or different groups selected from the group consisting of halogen, nitro, alkyl, alkoxy, halogenoalkyl, halogenoalkoxy ,X
When represents S, it further represents hydrogen: R3 represents hydrogen, alkyl, alkenyl, alkynyl, aralkyl The compound represented by is new, and in the following formula (V), X
represents 0 or S; R2 represents - or more, same or different groups selected from the group consisting of halogen, nitro, alkyl, alkoxy, halogenoalkyl, halogenoalkoxy;
When represents S, it further represents hydrogen; R3 represents hydrogen, alkyl, alkenyl, alkynyl, aralkyl The compound represented by is new, and in the following formula (Vl),
A compound represented by is obtained by heating in the presence of aqueous acid.
式(Vl)
式中、X、R”、R’、R’は上記意味を有し:
R“はアルキル又は随時置換したアリールを表し;
曹
R7は水素又は随時置換した一C
アル
キル、−C−アリールを表す
で表される化合物を、塩基の存在下、過熱することによ
って得る。Formula (Vl) In the formula, X, R'', R', R' have the above meanings: R'' represents alkyl or optionally substituted aryl; R7 is hydrogen or optionally substituted 1C alkyl, -C - for aryl is obtained by heating in the presence of a base.
式(■)
式中、X、R”、R’、R’l:!上記意味を有する
で表される化合物は新規であり、下記式(■)式中、X
、R”、R3,R’、R’及びR’は上記意味を有し、
R7がHを表すか、XがSを表すとき、R2は更に水素
を表すことができる
ルを表し;
で表される化合物は新規であり、まず下記式(■)式中
、X、R”、R’は上記意味を有す;で表される化合物
を、水性鉱酸の存在下、アルカリ金属ナイトライドでジ
アゾ化し、反応生成物を引き続き下記式(I[)
R’−CH,−GO−N−COOR−(I[)S
式中、R”、R’及びR1は上記意味を有する:
で表される化合物と反応させることにより得る。The compound represented by the formula (■) in which X, R'', R', R'l:! having the above meaning is new, and in the following formula (■), X
, R'', R3, R', R' and R' have the above meanings,
When R7 represents H or X represents S, R2 represents R which can further represent hydrogen; , R' has the above meaning; is diazotized with an alkali metal nitride in the presence of an aqueous mineral acid, and the reaction product is then converted into the following formula (I[) R'-CH,-GO -N-COOR-(I[)S In the formula, R'', R' and R1 have the above meanings: Obtained by reacting with a compound represented by the following.
好適に使用される式(I)で表される化合物はRIが随
時ハロゲン−、アルキル−、シアノ−、ニトロ−10−
アルキル−S
−アルキル−、ハロゲノアルキル−置換のフェニル、チ
アゾリル、オキサシリル、ベンゾチアゾリル又はベンゾ
オキサシリN
XがO,S又は−CH−を表し;
R2がハロゲン又はCl−8−アルキルを表し;
R3が水素又はCt −C4−アルキル、特にメチルを
表す
で表されるものである。The compound represented by formula (I) which is preferably used is such that RI is optionally halogen-, alkyl-, cyano-, nitro-10-
Alkyl-S-alkyl-, halogenoalkyl-substituted phenyl, thiazolyl, oxasilyl, benzothiazolyl or benzoxacylyN X represents O, S or -CH-; R2 represents halogen or Cl-8-alkyl; R3 represents represents hydrogen or Ct-C4-alkyl, especially methyl.
特に好適に使用される式(I)で表される化合物は
CN
Xが0又は−C)(−を表し;
R1がチアゾリル、ベンゾチアゾリル、ベンゾオキサシ
リル又はフェニルを表し、それぞれは随時C1−6−ア
ルキル、特にメf)k、C、−a−ハロゲノアルキル、
特にトリフルオロメチル、ノーロゲン特に塩素、臭素、
フッ素、ニトロ、CN−C5−a−アルコキシ、特にメ
トキシ、Cl−4−ハロゲノアルコキシ、特にトリフル
オロメトキシ、C,、−アルキルチオ、特にメチルチオ
、Cl−4−ハロゲノアルキルチオ、特にトリフルオロ
メチルチオで置換されていてもよく;
R1は水素又はハロゲン特に塩素、臭素、C11−アル
キル特にメチルからなる群から選ばれる−又はそれ以上
の基を表し;R3は水素を表す
で表されるものである。In the compound represented by the formula (I) which is particularly preferably used, CN alkyl, especially mef) k,C,-a-halogenoalkyl,
Especially trifluoromethyl, norogen especially chlorine, bromine,
substituted with fluorine, nitro, CN-C5-a-alkoxy, especially methoxy, Cl-4-halogenoalkoxy, especially trifluoromethoxy, C,,-alkylthio, especially methylthio, Cl-4-halogenoalkylthio, especially trifluoromethylthio R1 represents hydrogen or a group selected from the group consisting of halogen, especially chlorine, bromine, C11-alkyl, especially methyl; and R3 represents hydrogen.
非常に特に好適に使用される式(I)で表される化合物
は
Xが0を表し;
R1が随時塩素−、メチル−1又はトリフルオロメチル
−置換のチアゾリル又はベンゾチアゾリルを表し、;
R1は水素、メチル又は塩素からなる群から選ばれる−
又はそれ以上の基を表し;Rsは水素を表す
で表されるものである。Very particularly preferably used compounds of formula (I) are those in which X represents 0; R1 represents optionally chlorine-, methyl-1- or trifluoromethyl-substituted thiazolyl or benzothiazolyl; , methyl or chlorine -
or more groups; Rs represents hydrogen;
特別に好適に使用される式(I)で表される、他の化合
物は
CN
Xが−CH−を表し;
R1が随時塩素−、メチル−1又はトリフルオロメチル
−で置換されたフェニルを表し、;
R3は水素、塩素又はメチルからなる群から選ばれる、
同−若しくは異なる−又はそれ以上の基を表し;
R3は水素又はメチルを表す
で表されるものである。Other compounds of formula (I) which are particularly preferably used are those in which CN X represents -CH-; R1 represents phenyl optionally substituted with chlorine-, methyl-1 or trifluoromethyl- ,; R3 is selected from the group consisting of hydrogen, chlorine or methyl;
represents the same or different or more groups; R3 represents hydrogen or methyl;
特に下記化合物が例示される:
2−クロロ−a−(4−クロロフェニル)−4−(4,
5−ジヒドロ−3,5−ジオキソ−1゜2.4−)リア
ジン−2(3H)−イル)−フェニルアセトニトリル及
び
2.6−’;クロローσ−(4−10ロフエニル)−4
−(4,5−ジヒドロ−3,5−ジオキソ−1,2,4
−トリアジン−2(3H)−イル)−7エニルアセトニ
トリル。Particular examples include the following compounds: 2-chloro-a-(4-chlorophenyl)-4-(4,
5-dihydro-3,5-dioxo-1゜2.4-)riazin-2(3H)-yl)-phenylacetonitrile and 2.6-'; chloroσ-(4-10lophenyl)-4
-(4,5-dihydro-3,5-dioxo-1,2,4
-triazin-2(3H)-yl)-7enylacetonitrile.
更に下記のそれぞれの化合物が例示される:R8 Rア p暑 3−CH,6−C12 3CH36−CF@ 3−CH,5−C(2 3,5−CQ 6−CM 3.5−C126−CF。Furthermore, the following compounds are exemplified: R8 R a p heat 3-CH, 6-C12 3CH36-CF@ 3-CH,5-C(2 3,5-CQ 6-CM 3.5-C126-CF.
3.5−CQ 5−CM 更に下記化合物が挙げられる: −CQ −Br −F 6−CH。3.5-CQ 5-CM Further mention may be made of the following compounds: -CQ -Br -F 6-CH.
−0CH3 6−No。-0CH3 6-No.
−CN −CF3 6−3CF。-CN -CF3 6-3CF.
6−OCF。6-OCF.
−CQ −Br −F 6−CH。-CQ -Br -F 6-CH.
−0CH3 3CH3 CH3 3cHs −CQ −CQ −CQ −CQ 3 ’−CQ 3 ’−(I 3’−C12 3’−C12 3’−CQ 3’−CQ 3’−C(I 3’−(I 3’、5’−Cff 3’、5’−CM 3’、5’−C(2 X=−0 R3Rt 6−NO□ 6−No。-0CH3 3CH3 CH3 3cHs -CQ -CQ -CQ -CQ 3’-CQ 3’-(I 3'-C12 3'-C12 3'-CQ 3'-CQ 3'-C(I 3'-(I 3', 5'-Cff 3', 5'-CM 3', 5'-C(2 X=-0 R3Rt 6-NO□ 6-No.
−5CF3 −Cff −Br −F −CH5 6−OCH。-5CF3 -Cff -Br -F -CH5 6-OCH.
6−No。6-No.
−CN −CF3 6−SCF。-CN -CF3 6-SCF.
−0CF3 −0ff −Br −CH3 R1X −0 3’、5’−C12 3’、5’−CQ 3’、5’−Cff 3’、5’−C1+ 3’、5’−Cff 3’−CQ。-0CF3 -0ff -Br -CH3 R1X -0 3', 5'-C12 3', 5'-CQ 3', 5'-Cff 3', 5'-C1+ 3', 5'-Cff 3'-CQ.
5 ’ −CHs 3’−CQ。5’-CHs 3'-CQ.
5 ’ −c Hs 3 ’−CQ、 5 ’ −c Hs 3’−CQ。5’-c Hs 3'-CQ, 5’-c Hs 3'-CQ.
5 ’ −c Hs 3’−CQ。5’-c Hs 3'-CQ.
5 ’ −CHs 3’−CQ。5’-CHs 3'-CQ.
5 ’ −CH3 3’−CQ。5’-CH3 3'-CQ.
5’−CH。5'-CH.
R,R。R,R.
6−OCH。6-OCH.
6−No。6-No.
−CN −3CF3 −0CF3 −CI2 −Br −F 6−OCH3H −CN −CN X−OR R 3’−(I゜ 5 ’ −CHs 3’−CQ。-CN -3CF3 -0CF3 -CI2 -Br -F 6-OCH3H -CN -CN X-OR R 3'-(I゜ 5’-CHs 3'-CQ.
5’−CH。5'-CH.
3 ’−ca、 5’−C)1m 3’−CH3, 5’−CH3 3’−CH5, 5’−CH5 3’−〇Hz、 −CH3 3’−C11 3’−CH3 3’−CL 5’−CH。3’-ca, 5'-C) 1m 3'-CH3, 5'-CH3 3'-CH5, 5'-CH5 3’-〇Hz, -CH3 3'-C11 3'-CH3 3'-CL 5'-CH.
3’−CQ。3'-CQ.
5 ’−CQ 6−CF3 −5CF3 −CQ −ca −cm −Ci2 −C11 −Ca −CQ ca −Cg −CQ X−ORs 3’−Br 3’−Br。5’-CQ 6-CF3 -5CF3 -CQ -ca -cm -Ci2 -C11 -Ca -CQ ca -Cg -CQ X-ORs 3'-Br 3'-Br.
5’−Br 3’−CF。5'-Br 3'-CF.
3’−CF3. 5’−ca 3’−ca。3'-CF3. 5'-ca 3'-ca.
5’−cm 3’−CH。5'-cm 3'-CH.
3 ’−CQ、 s’−ca 3’−CH。3'-CQ, s'-ca 3'-CH.
R,R 6−Cff H 6−(l H 6−(l H 8−Cl1 H −ca 6−CQH CH,6−CQ H −C!H@ −Cm 3’−CQ 3’−C12 3’−CQ 3’−CH。R,R 6-Cff H 6-(l H 6-(l H 8-Cl1 H -ca 6-CQH CH, 6-CQ H -C! H@ -Cm 3'-CQ 3'-C12 3'-CQ 3'-CH.
3’−CH。3'-CH.
3’−CHl 3’−CQl 5 ’−CQ 3’−cm。3'-CHl 3'-CQl 5’-CQ 3'-cm.
5 ’−CQ CQ 3’−CL 5 ’−C11 ca 3’−CQ。5’-CQ CQ 3'-CL 5’-C11 ca 3'-CQ.
5 ’−CQ 3’−CH5 3’−CI2 5’−(I ca CF3 CH。5’-CQ 3'-CH5 3'-CI2 5'-(I ca CF3 CH.
3’−CH。3'-CH.
3’−CQ 5 ’−C11 3’−CH。3'-CQ 5’-C11 3'-CH.
HCQ CH,CQ C,H,Crt CF。H.C.Q. CH,CQ C,H,Crt C.F.
もし製造方法において、2.2− (3,5−ジクロロ
−4−ヒドロキシフェニル)−1,2,4−トリアジン
−3,5−(2H,4H)ジオンが化合物■として採用
され、2.6−ジクロロベンゾチアゾールが式(III
)で表される化合物として採用されるなら、プロセスは
下記反応式で表せよう。In the production method, if 2.2-(3,5-dichloro-4-hydroxyphenyl)-1,2,4-triazine-3,5-(2H,4H)dione is employed as compound ■, 2.6 -dichlorobenzothiazole of the formula (III
), the process can be expressed by the following reaction formula.
946c) 。946c).
R8が水素以外の基を表すときの式(II)で表される
化合物は新規である。The compound represented by formula (II) when R8 represents a group other than hydrogen is novel.
好ましいものとして挙げられる式(II)で表される化
合物は R2及びR3が式(I)の化合物において好ま
しいとして挙げられた意味を持つものである。Preferred compounds of formula (II) are those in which R2 and R3 have the meanings given as preferred in the compounds of formula (I).
下記の式1)で表される新規化合物がそれぞれ例示され
る。The novel compounds represented by the following formula 1) are exemplified.
し! R1及びR3が水素を表す、式 合物は公知である(J、5I Unio Pa1acki ac、Rerum、Nat。death! The formula in which R1 and R3 represent hydrogen The compound is known (J, 5I Unio Pa1acki ac, Rerum, Nat.
23)、39−45 ;c。23), 39-45; c.
(n)で表される化 ouka、Ac t a 01omuk、F 1984(Chem A、102 203 −CQ −CH3 3,5−CI2 3−CH,,5−CHs 3.5−CH。(n) ouka, Ac t a 01omuk, F 1984 (Chem. A, 102 203 -CQ -CH3 3,5-CI2 3-CH,,5-CHs 3.5-CH.
式(III)で表される置換複素環類は公知又は公知方
法と同様にして製造することができる(Beilste
in Vo+、27;Katrizky及びRees
、ComprehensiveHet、Chem、Co
1.6 1984)。The substituted heterocycle represented by formula (III) is known or can be produced in a similar manner to a known method (Beilste
in Vo+, 27; Katrizky and Rees
,ComprehensiveHet,Chem,Co
1.6 1984).
それらは式(I)で表される化合物のために上で示され
た好ましい意味を有する。下記の式([1)で表される
化合物がそれぞれ例示されよう。They have the preferred meanings given above for the compounds of formula (I). Compounds represented by the following formula ([1) may be exemplified.
S 6−(I
S 5.6−(I
06−CQ
0 5.6−Cl2
s 4−ca cmS
4.5−(l C(I04−CQ C
Q
o 4.5−CIl (I反応は好まし
くは希釈剤を用いて実施される。S 6-(I S 5.6-(I 06-CQ 0 5.6-Cl2 s 4-ca cmS
4.5-(l C(I04-CQ C
Q o 4.5-CIl (I reaction is preferably carried out using a diluent.
この製造方法のための好適な希釈剤は、実質的にすべて
の不活性有機溶媒である。これらは好適には脂肪族及び
芳香族の、適宜ハロゲン化された炭化水素類、ベンジン
、リグロイン、ベンゼン、トルエン、キシレン、メチレ
ンクロライド、エチレンクロライド、クロロ7オルム、
四塩化炭素、クロロベンゼン及び0−ジクロロベンゼン
、エーテル類例えばジエチルエーテル及びジブチルエー
テル、グリコールジメチルエーテル及びジグリコールジ
メチルエーテル、テトラヒドロ7ラン及びジオキサン、
ケトン類例えばアセトン、メチルエチルケトン、メチル
イソプロピルケトン及びメチルイソブチルケトン、エス
テル類例えば酢酸メチル及び酢酸エチル、ニトリル類例
えばアセトニトリル及びプロピオニトリル、アミド類例
えばジメチルフォルムアミド、ジメチルアセトアミド及
びN−メチルピロリドン、及びジメチルスルフォキサイ
ド
チルフォスフォリツクトリアミドを包含する。Suitable diluents for this manufacturing method are virtually all inert organic solvents. These are preferably aliphatic and aromatic, optionally halogenated hydrocarbons, benzine, ligroin, benzene, toluene, xylene, methylene chloride, ethylene chloride, chloro-7-olm,
carbon tetrachloride, chlorobenzene and 0-dichlorobenzene, ethers such as diethyl ether and dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether, tetrahydro7rane and dioxane,
Ketones such as acetone, methyl ethyl ketone, methyl isopropyl ketone and methyl isobutyl ketone, esters such as methyl acetate and ethyl acetate, nitriles such as acetonitrile and propionitrile, amides such as dimethylformamide, dimethylacetamide and N-methylpyrrolidone, and dimethyl Includes sulfoxide phosphoric triamide.
反応は無機又は有機の酸受容体の存在下で実施される。The reaction is carried out in the presence of an inorganic or organic acid acceptor.
酸受容体の例を述べれば:
アルカリ金属水酸化物、例えば水酸化ナトリウム及び水
酸化カリウム、アルカリ土類金属水酸化物、例えば水酸
化カルシウム、アルカリ金属炭酸塩及びアルカリ金属ア
ルコキサイド、例えば炭酸ナトリウム、炭酸カリウム、
ナトリウムメトキシド、カリウムメトキシド、ナトリウ
ムエトキシド、カリウムエトキシド、更に脂肪族、芳香
族又は複素環族のアミン、例えばトリエチルアミン、ピ
リジン、1.5−ジアザビシクロ−[4,3.01 −
ノン−5−エン(D B N)、1.8−ジアザビシク
ロ−[5.4,OJ −ウンデセ−7ーエン(DBU)
及び1.4−ジアザビシクロ−[2,2。Examples of acid acceptors are: alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, alkaline earth metal hydroxides such as calcium hydroxide, alkali metal carbonates and alkali metal alkoxides such as sodium carbonate, potassium carbonate,
Sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, as well as aliphatic, aromatic or heterocyclic amines such as triethylamine, pyridine, 1,5-diazabicyclo-[4,3.01-
Non-5-ene (DBN), 1,8-diazabicyclo-[5.4,OJ-undec-7-ene (DBU)
and 1,4-diazabicyclo-[2,2.
2]−オクタン(DABCO)である。2]-octane (DABCO).
反応は50℃〜200°Cの温度で、好ましくは80℃
〜160℃の温度で、大気圧下又は昇圧下実施される.
反応は好ましくは大気圧下で実施される。The reaction is carried out at a temperature of 50°C to 200°C, preferably 80°C.
It is carried out at a temperature of ~160°C under atmospheric pressure or elevated pressure.
The reaction is preferably carried out under atmospheric pressure.
反応は既述した希釈剤の一種中で式(II)及び(II
)で表される化合物を等モル量合体し、該混合物を加熱
することにより実施される。反応が完結したら、該反応
混合物を稀無機酸(例えば塩酸)を用いて酸性化し、生
成した沈殿物を濾過し、洗浄、乾燥する。The reaction is carried out in one of the diluents already mentioned for formulas (II) and (II).
) are combined in equimolar amounts and the mixture is heated. Once the reaction is complete, the reaction mixture is acidified using a dilute inorganic acid (eg hydrochloric acid) and the precipitate formed is filtered, washed and dried.
もし、R3が水素を表さないときの式(I)で表される
化合物の製造の為の方法2bにおいて、2− [4−[
2’ −ベンゾチアゾリルオキシ]フェニル] 1.
2.4−トリアジン−3.5−(2H。In process 2b for the production of compounds of formula (I) when R3 does not represent hydrogen, 2-[4-[
2'-Benzothiazolyloxy]phenyl] 1.
2.4-triazine-3.5-(2H.
4H)−ジオンを式(I a)で表される化合物として
採用し、ヨウ化メチルを式(IV)で表される化合物と
して採用すると、プロセスは下記反応式%式%
式(Ia)で表される化合物は新規であり、製造方法2
aで述べたようにして得られる。4H)-dione as the compound represented by formula (I a) and methyl iodide as the compound represented by formula (IV), the process is represented by the following reaction formula % Formula % Formula % Formula (Ia) The compound to be produced is new, and production method 2
Obtained as described in a.
式(IV)で表される化合物は公知であるか又は公知方
法で製造することができる。ヨウ化メチル及び臭化エチ
ルが特に挙げられる。Compounds represented by formula (IV) are known or can be produced by known methods. Methyl iodide and ethyl bromide may be mentioned in particular.
該反応は式(Ia)で表される化合物を、塩基及び希釈
剤の存在下、式(mV)で表される化合物と反応させる
ことにより実施される。使用し得る希釈剤は、製造方法
1aを実施するためにも用い得る、すべての不活性有機
溶媒である。The reaction is carried out by reacting a compound represented by formula (Ia) with a compound represented by formula (mV) in the presence of a base and a diluent. Diluents that can be used are all inert organic solvents that can also be used for carrying out production method 1a.
該反応は塩基の存在下に実施される。好ましい塩基を挙
げれば、アルカリ金属水酸化物、例えば水酸化ナトリウ
ム、アルカリ金属アルコキサイド、例えばナトリウムメ
トキシド又はカリウムブトキシド、金属水素化物、例え
ば水素化ナトリウム、又は有機塩基例えば1.8−ジア
ザビシクロ[5。The reaction is carried out in the presence of a base. Preferred bases include alkali metal hydroxides such as sodium hydroxide, alkali metal alkoxides such as sodium methoxide or potassium butoxide, metal hydrides such as sodium hydride, or organic bases such as 1,8-diazabicyclo[5.
4、OJ−ウンデセ−7ーエン(D B U)である。4, OJ-undec-7-ene (DBU).
該反応は大気圧下20℃〜140℃の温度で実施される
。The reaction is carried out at temperatures between 20°C and 140°C under atmospheric pressure.
反応は式(Ia)で表される化合物及び塩基を等モル量
合体し、該混合物に式(IV)で表される化合物を等モ
ル量添加し、該混合物を反応温度まで加熱することによ
り実施される。The reaction is carried out by combining equimolar amounts of the compound represented by formula (Ia) and a base, adding an equimolar amount of the compound represented by formula (IV) to the mixture, and heating the mixture to the reaction temperature. be done.
Xが一SO=又はーSO,−を表す式(I) −t’表
される化合物の製造の為のプロセス2c)において、2
− [4− (2’ −ベンゾオキサゾリルチオ)フェ
ニル]’1.2.4ートリアジン−3.5−(2H.4
H)−ジオンが式(I)で表される化合物として採用さ
れるなら、該プロセスは下記略図で記述できる。In process 2c) for the production of a compound of formula (I) -t' in which X represents one SO= or -SO,-,
-[4-(2'-Benzoxazolylthio)phenyl]'1.2.4 triazine-3.5-(2H.4
If H)-dione is taken as the compound of formula (I), the process can be described in the diagram below.
で上記した希釈剤中数時間撹拌することにより実該製造
方法はx−8である式(りで表される化合物を希釈剤の
存在下酸化剤で処理することにより実施できる。好適に
用い得る酸化剤としては、過酸化水素及び他の無機過酸
化物、例えば過酸化ナトリウム、有機パーオキソ酸、例
えばm−クロロ過安息香酸、ヨウ素と酸素の化合物例え
ばソジウムメタパーイオデイトである。In fact, the production method can be carried out by treating a compound represented by the formula x-8 with an oxidizing agent in the presence of a diluent. Oxidizing agents include hydrogen peroxide and other inorganic peroxides, such as sodium peroxide, organic peroxoacids, such as m-chloroperbenzoic acid, and compounds of iodine and oxygen, such as sodium metaperiodite.
好適に使用し得る希釈剤は:アルコール類、例えばメタ
ノール、有機酸、例えば酢酸、及びケトン類、例えばア
セトンであり、更にハロゲン化炭化水素類、例えばジク
ロロメタン、又は酸無水物、例えば無水酢酸も使用し得
る。酸化は0℃〜120°Cの温度で実施される。圧力
は好ましくは大気圧下で実施される。Diluents that can be preferably used are: alcohols, such as methanol, organic acids, such as acetic acid, and ketones, such as acetone, but also halogenated hydrocarbons, such as dichloromethane, or acid anhydrides, such as acetic anhydride. It is possible. Oxidation is carried out at temperatures between 0°C and 120°C. The pressure is preferably carried out under atmospheric pressure.
酸化剤の量は1モルから10倍モルの範囲で変化できる
。該反応はx−5である式(I)の化合物を上記した酸
化剤と一緒に、上記した反応温度施できる。The amount of oxidizing agent can vary from 1 molar to 10 times molar. The reaction can be carried out using a compound of formula (I), x-5, together with an oxidizing agent as described above, at the reaction temperature as described above.
N
Xが−CH−を表し、R1がフェニルを表す式(I)で
表される1、2.4−トリアジンジオン類が哺乳動物及
び鳥のコクシジア(Coccidia)の防除に用い得
ることは知られていた。この作用は未知の式(I)で表
される化合物に対しても暗示される。魚類寄生虫の防除
のための式(I)の化合物の使用可能性については何も
知られていない。It is known that 1,2,4-triazinediones represented by the formula (I) in which NX represents -CH- and R1 represents phenyl can be used for controlling Coccidia in mammals and birds. was. This effect is also implied for unknown compounds represented by formula (I). Nothing is known about the possible use of compounds of formula (I) for the control of fish parasites.
魚類寄生虫とは、原生動物亜界の、繊毛虫類−の種、例
えばイキチオフチリウスマルチフイリイス(I cht
hyophthirius multifiliis
) 、チロドネラシプリニ(Chilodonella
cyprini)、トリコデナ s p 、 (
Trichodina spp、 ) 、グロッサテ
ラ s p 、 (GIossaLeNa Sp9
.) 、エビスチリス s p−(Epistylis
spp、) 、粘液胞子虫煩悶の種、例えばミキソ
ゾーマセレプラリス(Myxosoma cerab
ralis)、ミキシジウムs p +(Myxidi
um spp、) 、ミキソボラス Sp 、 (
Myxobolus spp、 ) 、ヘネグヤ s
p。Fish parasites are species of the ciliates of the protozoan sub-kingdom, such as Ichthyophthyrius multifilis (I cht
hyophthirius multifiliis
), Chilodonella ciplini (Chilodonella
cyprini), Trichodena sp, (
Trichodina spp, ), Glossatella sp, (GIossaLeNa Sp9
.. ), Epistylis sp- (Epistylis
spp, ), species of myxosporidoids, such as Myxosoma cerebralis (Myxosoma cerebralis)
ralis), Myxidium sp + (Myxidi
um spp, ), Myxoborus Sp, (
Myxobolus spp, ), Heneguya s
p.
(Heneguya 5pp−) s ホフェレラス
sp、(Hoferellus spp、) 、微
胞子虫類綱の種、例えばグルゲア s p、 (Gl
ugea 5pp−) 、セロハニア s p 、
(Thelohania spp、) 、プレイス
ト7オラ s p 、 (Pleistophora
spp、) 、扁形動物門:吸虫類:半生類、例え
ばダクチロギラスs p 、 (DactylogY
rus spp、 ) 、ギロダクチラス s p
、 (Gyrodactylus spp、) %
シュードダクチロギラス s p 、 (Pseud
odacLylogyruSSpp、)、ディプロズー
ン 5 p 、 (Diploz。(Heneguya 5pp-) s Hoferellus sp, (Hoferellus spp,), species of the microsporidian class, such as Gurgea sp, (Gl
ugea 5pp-), Cellophanea sp,
(Thelohania spp,), Pleistophora sp, (Pleistophora
spp, ), phylum Platyhelminthes: Trematoda: Hemizoa, e.g. Dactylogylus sp, (DactylogY
rus spp, ), Gyrodactylus sp.
, (Gyrodactylus spp,) %
Pseudodactylogillus sp, (Pseud
odacLylogyruSSpp, ), Diploz 5 p, (Diploz.
on spp、 ) 、条虫類、例えば丁字虫群(例
えばキャリオフィラウスラティセプス(Caryoph
yllaeus 1aticeps) 、凝集類(例
えばディフィロポツリウム s p 、 (D ip
hylloboLhrium spp、))、四葉類
(例えばフィロポツリウム sp、(Phy11obo
thriu+m spp、) )及び変頭類(例えば
プロテオセファルス(P roLeocephalus
)属の種)、及び節足動物門の種々の寄生性甲殻類、特
に鱈尾類亜綱(魚寄生虫)及びカイアシ類(カイアシ類
動物)及び等脚註(等押目甲殻類)及び端脚目(ミジン
コ)が包含される。on spp, ), tapeworms, e.g.
yllaeus 1aticeps), aggregates (e.g. Diphyllopotulium sp, (Dip
hyllobo Lhrium spp, )), Tetrafolia (e.g. Phyllopotulium sp, (Phy11obo
thriu+m spp, ) and metacephalians (e.g. ProLeocephalus
) species), and various parasitic crustaceans of the phylum Arthropoda, especially the subclasses Codocuroda (fish parasites) and copepods (copepods) and isopods (isoopods) and arthropods. Includes Daphnia.
魚には、真水又は海水に住む全ての齢の、経済的に有用
な魚、養殖魚、水槽魚及び鑑賞魚を包含する。経済的に
有用な魚及び養殖魚には例えば鯉、鰻、鱒、シロマス、
鮭、ブリーム、ローチ、ラッド、ドビュレ(dobul
e) 、シタビラメ、アカガレイ、オヒョウ、日本ブリ
(S eriola quinqueradiata
) 、日本鰻(Anguilla japonica
) 、紅海ブリーム(Pagurus major)
、スズキ(D 1cenLrarchus 1ab
rax)、ボラ(Mugilus cephalus
)、コバンアジ(poIlpano) 、クロダイ類(
S parusauratus) 、テラピア種、チチ
リダエ種(Chichlidae 5pecies)
、例えばブラシオシオン(P lagioscion
) 、ブチナマズが含まれる。本発明による薬剤は、特
に幼魚、例えば体長2 4cmの鯉を処置するのに好適
である。本薬剤は鰻肥大にも非常に好適である。Fish includes economically useful fish, farmed fish, aquarium fish and ornamental fish of all ages living in fresh or salt water. Economically useful fish and farmed fish include carp, eel, trout, white trout,
Salmon, bream, roach, rudd, dobule
e), sole, flathead flounder, halibut, Japanese yellowtail (S eriola quinqueradiata)
), Japanese eel (Anguilla japonica)
), Red Sea Bream (Pagurus major)
, perch (D 1cenLrarchus 1ab
rax), Mullet (Mugilus cephalus)
), black porgy (poIlpano), black porgy (
S parusauratus), Tilapia species, Chichlidae 5pecies
, for example, Plagioscion.
), including spotted catfish. The medicament according to the invention is particularly suitable for treating young fish, for example carp with a body length of 24 cm. This drug is also very suitable for eel enlargement.
魚の処置は経口的に、例えば食物を経由して、あるいは
例えばある養魚槽から他の養魚槽に移動するとき、′薬
浴″′に魚をある時間(数分から数時間)入れておくと
いう短時間処置によって実施される。Treatment of fish can be done orally, for example via food, or for short periods of time (from minutes to hours) by keeping the fish in a 'medicated bath', for example when moving from one fish tank to another. It is carried out by time treatment.
しかし魚が保存されている環境(例えば池、養魚池、槽
又は水槽全体)の−時的又は永久的処置が効果的である
。However, temporary or permanent treatment of the environment in which the fish are kept (e.g. ponds, fishponds, tanks or entire tanks) is effective.
活性化合物は適用に合わせて計画された調合剤中で供給
される。The active compounds are supplied in formulations tailored to the application.
経口適用のための調合剤は粉末剤、顆粒剤、溶液剤、乳
化濃厚物又は懸濁濃厚物であり、それらは食物添加物と
して食物と均一に混合される。Preparations for oral application are powders, granules, solutions, emulsion concentrates or suspension concentrates, which are homogeneously mixed with food as food additives.
該調合剤はそれ自身公知の方法で、活性化合物を固体又
は液体担体と、もし適当ならば更に他の活性化合物及び
乳化又は懸濁化剤、溶解剤、着色剤、抗酸化剤、防腐剤
と混合することにより製造される。The preparations are prepared in a manner known per se by combining the active compound with a solid or liquid carrier and, if appropriate, further active compounds and emulsifying or suspending agents, solubilizing agents, colorants, antioxidants and preservatives. Manufactured by mixing.
固体担体とは例えば天然麿砕鉱物、例えばカオリン、粘
土、雲母、白亜、けいそう土、有機担体、例えば砂糖、
蔗糖、乳糖、フルクトース、穀物生産物、例えば微細な
又は粗な穀物粉、澱粉、動物粉、セルロース、粉末ミル
ク、無機担体、例えば一般塩、炭酸塩、例えば炭酸カル
シウム、炭酸水素塩、酸化アルミニウム、シリカ、シリ
ケートを包含する。Solid carriers include, for example, natural crushed minerals such as kaolin, clay, mica, chalk, diatomaceous earth, organic carriers such as sugar,
sucrose, lactose, fructose, cereal products such as fine or coarse flour, starch, animal flour, cellulose, powdered milk, inorganic carriers such as common salts, carbonates such as calcium carbonate, bicarbonate, aluminum oxide, Includes silica and silicates.
液体担体及び溶解剤とは、水、アルカノール類、例工ば
エタノール、インプロパツール、グリコール類、例えば
エチレングリコール、プロピレングリコール、ポリエチ
レングリコール、ポリプロピレングリコール、及びそれ
らのコポリマー、グリセロール、芳香族アルコール類
、例えばベンジルアルコール、フェニルエタノール、フ
ェノキシエタノール、エステル類、例えば酢酸エチル、
酢酸ブチル、安息香酸ベンジル、エーテル類、例えばア
ルキレングリコールアルキルエーテル、例えばジグロピ
レングリコール七ツメチルエーテル、ジエチレングリコ
ールモノブチルエーテル、ケトン類、例えばアセトン、
メチルエチルケトン、芳香族及び/又は脂肪族炭化水素
類、植物又は合成油、DMF、DMSO,ジメチルアセ
トアミド、N−メチルピロリドン、2−ジメチル−4−
オキシメチレン−1,3−ジオキサロンを包含する。Liquid carriers and solubilizers include water, alkanols such as ethanol, impropatol, glycols such as ethylene glycol, propylene glycol, polyethylene glycol, polypropylene glycol, and copolymers thereof, glycerol, and aromatic alcohols.
, such as benzyl alcohol, phenylethanol, phenoxyethanol, esters such as ethyl acetate,
Butyl acetate, benzyl benzoate, ethers such as alkylene glycol alkyl ethers such as diglopylene glycol hetmethyl ether, diethylene glycol monobutyl ether, ketones such as acetone,
Methyl ethyl ketone, aromatic and/or aliphatic hydrocarbons, vegetable or synthetic oils, DMF, DMSO, dimethylacetamide, N-methylpyrrolidone, 2-dimethyl-4-
Includes oxymethylene-1,3-dioxalone.
乳化及び懸濁化剤とは:非イオン形成性界面活性剤、例
えばポリオキシエチル化ヒマシ油、ポリオキシエチル化
ソルビタンモノオレエート、ソルビタンモノステアレー
ト、グリセロールモノステアレート、ポリオキシエチレ
ンステアレート、アルキルフェノールポリグリコールエ
ーテル、両性界面活性剤類、例えばラウリルβ−イミノ
ジプロピオン酸2ナトリウム、又はレシチン、陰イオン
活性界面活性剤、例えばラウリル硫酸ナトリウム、脂肪
アルコールエーテル硫酸塩、モノ/ジアルキルポリグリ
コールエーテルオルソフォスフェートのモノエタノール
アミン塩、陽イオン活性界面活性剤、例えばセチルトリ
メチルアンモニウムクロライドが包含される。Emulsifying and suspending agents: non-ion-forming surfactants, such as polyoxyethylated castor oil, polyoxyethylated sorbitan monooleate, sorbitan monostearate, glycerol monostearate, polyoxyethylene stearate, Alkylphenol polyglycol ethers, amphoteric surfactants such as disodium lauryl β-iminodipropionate, or lecithin, anionic active surfactants such as sodium lauryl sulfate, fatty alcohol ether sulfates, mono/dialkyl polyglycol ethers, etc. Included are the monoethanolamine salt of sophosphate, cationically active surfactants such as cetyltrimethylammonium chloride.
調整剤中では、活性化合物の濃度は約lppm〜lO重
量%である。In the regulator, the concentration of active compound is approximately 1 ppm to 10% by weight.
例えば魚が移動するとき適用される、”薬浴”として適
用される短時間処置、又は魚の棲息地処置(池装置)の
為の好ましい調合剤は、水での希釈の際にアルカリ性反
応を示す−又はそれ以上の極性溶媒による活性化合物溶
液である。Preferred preparations for short-term treatments applied as "medicated baths" or for fish habitat treatments (pond systems), for example applied when fish migrate, exhibit an alkaline reaction upon dilution with water. - or more polar solvent solutions of the active compound.
かかる溶液の製造のために、該活性化合物をそれ自身ア
ルカリ性反応を示す、又はアルカリ性水溶性物質を添加
されてアルカリ性反応を示す極性水溶性溶媒に溶解する
。後者は有利には同様に溶媒に溶解されるが、水と接触
したとき初めて溶解するように溶媒中に懸濁させること
もできる。この場合、水は活性化合物が添加された後で
、pH7−10、好ましくはpH8−10であるべきで
ある。For the preparation of such solutions, the active compound is dissolved in a polar water-soluble solvent which itself exhibits an alkaline reaction or which exhibits an alkaline reaction with the addition of alkaline water-soluble substances. The latter are preferably dissolved in the solvent as well, but they can also be suspended in the solvent in such a way that they only dissolve on contact with water. In this case, the water should have a pH of 7-10, preferably pH 8-10 after the active compound has been added.
活性化合物濃度は0.5−50%、好ましくは1−25
%範囲で有り得る。The active compound concentration is 0.5-50%, preferably 1-25%
Possible within the % range.
適切な溶媒はすべて水溶性溶媒であり、それに活性化合
物が充分な濃度で溶解でき、生理学的にも許容されるも
のである。All suitable solvents are aqueous solvents in which the active compound can be dissolved in sufficient concentrations and which are physiologically acceptable.
このような溶媒はエチルアルコール、イソプロピルアル
コール、ベンジルアルコール、グリセロール、プロピレ
ングリコール、ポリエチレングリコール、ポリ(オキシ
エチレン)/ポリ(オキシプロピレン)ポリマー類、塩
基性アルコール、例えばモノ−、ジー及びトリエタノー
ルアミン、ケトン類、例えばアセトン又はメチルエチル
ケトン、エステル類、例えば乳酸エチル、更にN−メチ
ルピロリドン、ジメチルアセトアミド、ジメチルフォル
ムアミド、更に懸濁化及び乳化剤、例えばポリオキシエ
チル化ヒマシ油、ポリエチレングリコールソルビタンモ
ノオレエート、ポリエチレングリコールステアレート又
はポリエチレングリコールエーテル、ポリエチレングリ
コールアルキルアミンである。Such solvents include ethyl alcohol, isopropyl alcohol, benzyl alcohol, glycerol, propylene glycol, polyethylene glycol, poly(oxyethylene)/poly(oxypropylene) polymers, basic alcohols such as mono-, di-, and triethanolamine, Ketones, such as acetone or methyl ethyl ketone, esters, such as ethyl lactate, and also N-methylpyrrolidone, dimethylacetamide, dimethylformamide, and also suspending and emulsifying agents, such as polyoxyethylated castor oil, polyethylene glycol sorbitan monooleate, These are polyethylene glycol stearate, polyethylene glycol ether, and polyethylene glycol alkylamine.
アルカリ性pHを調整するために例示される塩基は、有
機塩基、例えば塩基性アミノ酸、例えばL−又はり、L
−アルギニン、L−又はり、L−リジン、メチルグルコ
サミン、グルコサミン、2アミノ−2−ヒドロキシメチ
ルプロパン−(I゜3)−ジオール、例えば更にN、N
、N’ 、N″テトラキス=2−ヒドロキシプロピル)
−エチレンジアミン又はエチレンジアミンをベースにし
たポリエーテルテトロール(M、W、480−420)
、無機塩基、例えばアンモニア又は炭酸ナトリウム(も
し適切ならば水を添加)が挙げられる。Exemplary bases for adjusting the alkaline pH include organic bases, such as basic amino acids, such as L- or
- arginine, L-ori, L-lysine, methylglucosamine, glucosamine, 2-amino-2-hydroxymethylpropane-(I°3)-diol, such as further N, N
, N', N''tetrakis=2-hydroxypropyl)
- ethylenediamine or polyether tetrols based on ethylenediamine (M, W, 480-420)
, inorganic bases such as ammonia or sodium carbonate (with addition of water if appropriate).
調合剤は0.1〜20重量%、好ましくは0゜1−10
重量%の他の調整補助剤、例えば抗酸化剤、界面活性剤
、懸濁安定化剤、及び稠密化剤、例えばメチルセルロー
ス、アルギン酸塩、ポリサッカライド、ガラクトマンナ
ン、及びコロイダルシリカを含有してもよい。また動物
飼育用の着色剤、香料及び栄養成分を添加することもで
きる。初めに混入させた塩基と共に緩衝系を形成するか
、又は溶液のpHを減少させる酸類も、同様の意味で挙
げることができる。The formulation contains 0.1-20% by weight, preferably 0°1-10
May also contain weight percent of other conditioning aids such as antioxidants, surfactants, suspension stabilizers, and densifying agents such as methylcellulose, alginates, polysaccharides, galactomannans, and colloidal silica. . It is also possible to add colorants, fragrances and nutritional ingredients for animal breeding. Mention may also be made in a similar sense of acids which together with the initially introduced base form a buffer system or which reduce the pH of the solution.
適用に当たっての活性化合物濃度は、処置の形態と期間
及び処置される魚の年令とコンデイションによる。例え
ば、短時間処置にあっては、3−4時間の処理時間で、
−リットルの水に対して250mg好ましくは5−10
mgである。例えば、若い鯉は5−10mg/(lの濃
度で約1−4時間処置される。The active compound concentration for application depends on the form and duration of the treatment and on the age and condition of the fish being treated. For example, for short-term treatment, the treatment time is 3-4 hours,
- 250 mg preferably 5-10 per liter of water
mg. For example, young carp are treated with a concentration of 5-10 mg/(l) for about 1-4 hours.
鰻は約5 m g / Qで約4時間処置される。The eel is treated with about 5 mg/Q for about 4 hours.
対応の低濃度は処置時間が長いとき、又は永久処置が実
施されるときに選ばれる。Correspondingly lower concentrations are chosen when treatment times are long or when permanent treatment is carried out.
池処置のためには、水−リットル当たり0. 1−5m
gの活性化合物が用いられる。For pond treatment, water - 0. 1-5m
g of active compound is used.
食物添加物としての使用のための調整物は、下記組成を
持ち得る:
a)式(I)の活性化′合物 1−10重量部大豆蛋
白 49−90重量部b)式(I)の活性
化合物0.5−10重量部ベンジルアルコール
0.08−1.4重量部
ヒドロキシプロピルメチルセルロース
0−3.5重量部
水で100重量部とする
′°薬浴”としての利用及び池処置としての利用の為の
調合剤は下記組成であることができ、また下記の如くに
製造することができる:
C)実施例4の活性化合物2.5gを、加熱下100m
ffのトリエタノールアミンに溶解する。A preparation for use as a food additive may have the following composition: a) Activated compound of formula (I) 1-10 parts by weight soy protein 49-90 parts by weight b) Activated compound of formula (I) Active compound 0.5-10 parts by weight Benzyl alcohol 0.08-1.4 parts by weight Hydroxypropyl methylcellulose 0-3.5 parts by weight Water to 100 parts Use as 'Medicated bath' and as pond treatment The preparation for use can have the following composition and can be prepared as follows: C) 2.5 g of the active compound of Example 4 are heated under heating for 100 m
ff dissolved in triethanolamine.
d)実施例4の活性化合物2.5gと乳酸12゜5gを
、加熱及び撹拌下100rrlのトリエタノールアミン
に溶解する。d) 2.5 g of the active compound of Example 4 and 12.5 g of lactic acid are dissolved in 100 rrl of triethanolamine under heating and stirring.
e)実施例4の活性化合物10.0gをloomQのモ
ノエタノールアミンに溶解する。e) Dissolve 10.0 g of the active compound of Example 4 in roomQ monoethanolamine.
f)式(I)の活性化合物 5.0gプロピレング
リコール 50.0g
炭酸ナトリウム 5.0g
水で100m(2にする
g)式(I)の活性化合物 5.0gモノエタノー
ルアミン 10 gN−メチルピロリドンでlo
omQにするh)式(I)の活性化合物 2.5g
炭酸ナトリウム 5.0g
ポリエチレングリコール 200
で100m12にする
該活性化合物を加熱下ポリエチレングリコールに溶解し
、その溶液に炭酸ナトリウムを分散する。f) Active compound of formula (I) 5.0 g Propylene glycol 50.0 g Sodium carbonate 5.0 g 100 m with water (2 g) Active compound of formula (I) 5.0 g Monoethanolamine 10 g N-methylpyrrolidone lo
h) 2.5 g of active compound of formula (I)
Sodium carbonate 5.0 g Polyethylene glycol 200 Make up to 100 ml The active compound is dissolved in polyethylene glycol under heating and the sodium carbonate is dispersed in the solution.
哀1」L配
寄生虫の1n−VitrO処置
温度22℃の水150m<1を入れ、指定濃度の実施例
4の活性化合物を添加したガラス皿に、表示された種の
寄生虫を移した。指定された時間の経過後、光学顕微読
下寄生虫を検査した。下記のごとき観測結果であった:
寄生虫 濃度/時間 寄生虫の観察イキチオ
7チリウス 10ppm/ 死亡マルチフイリイス
15分
(Ichthyophthirius
multifiliis)
シュードダクチロギラス
アンギラエ 10ppm/ 麻痺(Pse
udodactylo−1−10分gyrus ang
uillae)
デイプロゾーン l Oppm/ 死亡ホモイ
オン 90分
(Diplozoon
homoion)
実施例B
魚の1n−vivo処置
ギロダクチラスアルキュアタス(G yrodacty
lus arcuatus)で重度に蔓延されたトゲ
ウォ(Sticklebacks)を、実施例4の活性
化合物10ppmを添加した水2Oa中で、22℃で一
時間処置した。この後で魚を検査した。それらには寄生
虫が存在しなかった。沈殿物には死亡した、又は致命的
に損傷した虫が含まれていた。Parasites of the indicated species were transferred to glass dishes containing 150 ml of water at a temperature of 22° C. and supplemented with the indicated concentration of the active compound of Example 4. After the specified time, parasites were examined under light microscopy. The observation results were as follows: Parasite concentration/time Observation of parasites Ichthyophthirius 10 ppm / Dead Ichthyophthirius multifiliis 15 minutes (Ichthyophthirius multifiliis) Pseudodactylogillus anguillae 10 ppm / Paralysis (Pse)
udodactylo-1-10 minutes gyrus ang
Example B 1n-vivo treatment of fish Gyrodactylus alcuatus
Sticklebacks heavily infested with P. lus arcuatus were treated for 1 hour at 22° C. in 2 Oa of water supplemented with 10 ppm of the active compound of Example 4. After this the fish were examined. There were no parasites present on them. The sediment contained dead or fatally injured insects.
活性化合物の例
実施例1
2− [4−[(4″−クロロ)−2′−チアシリロキ
シ]フェニル]−3,5(2H,4H)−ジオキソ−ア
ズ−トリアジン
29g (0,01モル)のヒドロキシフェニルアザウ
ラシル、1.5g (0,01モル)のジクロロチアゾ
ール及び1.4g (0,01モル)の炭酸カリウムを
、20mQの乾燥DMF中2時間還流下撹拌する。反応
混合物を冷却し、HCQを用いて酸性化し、沈澱生成物
を吸引下濾別する。Examples of active compounds Example 1 29 g (0,01 mol) of 2-[4-[(4″-chloro)-2′-thiacylyloxy]phenyl]-3,5(2H,4H)-dioxo-az-triazine Hydroxyphenylazauracil, 1.5 g (0.01 mol) dichlorothiazole and 1.4 g (0.01 mol) potassium carbonate are stirred under reflux in 20 mQ dry DMF for 2 hours. The reaction mixture is cooled and Acidify with HCQ and filter off the precipitated product under suction.
エタノール再結により、2.9g、(理論値の90%)
のチアシリロキシアリールアザウラシルが得られる。By ethanol reconsolidation, 2.9g (90% of theoretical value)
thiacyloxyaryl azauracil is obtained.
下記の物が同様にして得られる。The following can be obtained in the same way.
実施例2
2− [4−[(4’ −クロロ−5′−メチル)−2
′−チアシリロキシ]フェニル] 1.2.4−トリ
アジン−3,5(2H,4H)−ジオン実施例3
2−(4−(2−ベンゾチアシリロキシ)−フェニル)
−1,2,4−トリアジン−3,5(2H。Example 2 2-[4-[(4'-chloro-5'-methyl)-2
1.2.4-triazine-3,5(2H,4H)-dione Example 3 2-(4-(2-benzothiacylyloxy)-phenyl)
-1,2,4-triazine-3,5(2H.
4H)−ジオン
実施例4
2− [4−[(6’−クロロ)−2′−ベンゾチアシ
リロキシ]−3,5−ジクロロフェニル〕−1,2,4
−トリアジン−3,5(2H,4H)−ジオン
実施例4a
2− [4−[(6’−1−リフロロメチル)−2″−
ベンゾチアシリロキシ] −3,5−ジクロロフェニル
] 1.2.4−)リアジン−3,5(2H。4H)-dione Example 4 2-[4-[(6'-chloro)-2'-benzothiacylyloxy]-3,5-dichlorophenyl]-1,2,4
-Triazine-3,5(2H,4H)-dione Example 4a 2-[4-[(6'-1-lifluoromethyl)-2''-
benzothiasylyloxy] -3,5-dichlorophenyl] 1.2.4-) riazine-3,5(2H.
4H)−ジオン
実施例4b
2− [4−[(6″−トリフロロメトキシ)−2′−
ベンゾチアゾリロキシ]−3,5−ジクロロフェニル]
1,2.4−トリアジン−3,5(2H。4H)-dione Example 4b 2-[4-[(6″-trifluoromethoxy)-2′-
benzothiazolyloxy]-3,5-dichlorophenyl]
1,2,4-triazine-3,5(2H.
4H)−ジオン
実施例4c
2− [4−[(6’−1−リフロロメチルチオ)−2
′−ベンゾチアシリロキシ]−3,5−ジクロロフェニ
ル] 1.2.4−)リアジン−3,5(2H,4H
)−ジオン
実施例4d
2− [4−[(5’ 、6″−ジクロロ)−2′ベン
ゾチアシリロキシ]−3,5−ジクロロフェニル]
1.2.44リアジン−3,5(2H。4H)-dione Example 4c 2-[4-[(6'-1-lifluoromethylthio)-2
'-benzothiacylyloxy]-3,5-dichlorophenyl] 1.2.4-) riazine-3,5(2H,4H
)-dione Example 4d 2-[4-[(5',6''-dichloro)-2'benzothiacylyloxy]-3,5-dichlorophenyl]
1.2.44Ryazine-3,5(2H.
4H)−ジオン
実施例5
2− [4−[(4’−クロロ)−2′−チアシリロキ
シ]フェニル]−3−N−メチルー−3゜5− (2H
,4H)−ジオキソ−1,2,4−トリアジン
加する。該混合物を50°Cに昇温し、この温度で3時
間維持する。引き続き反応混合物を真空下濃縮し、その
模本を添加する。固体沈殿物を吸引濾別した後、1.5
g (理論値の71%)のn−メチル化合物が得られる
。4H)-dione Example 5 2-[4-[(4'-chloro)-2'-thiacylyloxy]phenyl]-3-N-methyl-3°5- (2H
,4H)-dioxo-1,2,4-triazine. The mixture is heated to 50°C and maintained at this temperature for 3 hours. The reaction mixture is then concentrated under vacuum and the sample is added. After filtering off the solid precipitate with suction, 1.5
g (71% of theory) of n-methyl compound is obtained.
実施例6a
2− [4−[(6−クロロ)−2′ −ベンゾオキサ
シリルスル7オキシル] −3,5−ジクロロフェニル
] l、2.4−トリアジン−3,5(2H。Example 6a 2-[4-[(6-chloro)-2'-benzoxasilylsul7oxyl]-3,5-dichlorophenyl]l, 2,4-triazine-3,5(2H.
4H)−ジオン
2g(6ミリモル)のチアシリロキシアリールアザウラ
シルを20m+2の無水DMSOに溶解し、その溶液に
0.14g(6ミリモル)の水素化ナトリウムを添加す
る。該混合物を20分間還流温度で撹拌し、5mQのD
MSO中の1.3g(9ミリモル)のヨウ化メチルをア
ルゴン雰囲気下話10g (0,027モル)のクロロ
ベンゾオキサゾリルチオフェニルアザウラシルを200
mQのメタノールとloOmQのジクロロメタンとの混
合物に溶解する。該混合物をlOoCに冷却し、4.6
gのm−クロロ過安息香酸(85%強度)を同温皮下添
加する。10℃でloh撹拌を続け、溶媒を真空下留去
し、残渣をインプロパツールから再結する。8.5g(
理論値の82%)のスルフォキサイド物が得られる。4H)-Dione 2 g (6 mmol) of thiacyryloxyarylazauracil are dissolved in 20 m+2 of anhydrous DMSO and 0.14 g (6 mmol) of sodium hydride are added to the solution. The mixture was stirred for 20 minutes at reflux temperature and 5 mQ of D
1.3 g (9 mmol) of methyl iodide in MSO was mixed with 10 g (0,027 mol) of chlorobenzoxazolylthiophenyl azauracil under an argon atmosphere.
Dissolve in a mixture of mQ methanol and loOmQ dichloromethane. The mixture was cooled to lOoC and 4.6
g of m-chloroperbenzoic acid (85% strength) is added isothermally subcutaneously. Continue loh stirring at 10°C, remove the solvent under vacuum and reconstitute the residue from Improper Tool. 8.5g (
A sulfoxide of 82% of theory is obtained.
実施例6b
2− [4−(2″−ベンゾオキサシリルスル7オキシ
ル
4−トリアジン−3.5 (2H,4H)−ジオン実施
例7
2− [4− (2″−ベンゾオキサシリルスル7オキ
シル
4−トリアジン−1.2.4−トリアジン−3。Example 6b 2-[4-(2''-Benzoxacylylsul7oxyl 4-triazine-3.5 (2H,4H)-dione Example 7 2-[4-(2''-Benzoxacylylsul7oxyl) 4-triazine-1.2.4-triazine-3.
5 (2H,4H)−ジオン
実施例8
2− [4− [(6’−クロロ)−2′ −へンゾオ
キサゾリルスル7ォニル]−3.5−ジクロロフェニル
3 1,2.4−トリアジン−3.5 (2H。5 (2H,4H)-dione Example 8 2-[4-[(6'-chloro)-2'-henzooxazolylsulfonyl]-3.5-dichlorophenyl3 1,2.4-triazine -3.5 (2H.
4H)−ジオン
8、8g (0.02モル)のクロロベンゾオキサゾリ
ルチオフェニルアザウラシルを100m12の氷酢酸に
溶解し、該溶液を30%強度の過酸化水素40mQと共
に18時間還流下撹拌する。該混合物を冷却した後、水
を添加し、形成した沈殿物を吸引濾別する。インプロパ
ツールからの再結で6.9gのスルフォン(理論値の7
3%)が得られる。8.8 g (0.02 mol) of the 4H)-dione are dissolved in 100 ml of glacial acetic acid and the solution is stirred under reflux for 18 hours with 40 mQ of 30% strength hydrogen peroxide. After the mixture has cooled, water is added and the precipitate that has formed is filtered off with suction. 6.9 g of sulfone (theoretical value of 7
3%) is obtained.
実施例9
2− [4− (2’ −ベンゾオキサシリルスルフォ
ニル)−3.5−ジクロロフェニル] l,2.4ト
リアジン−3,5(2H,4H)−ジオン烹」11上」
−
2−[4−(2’ −ベンゾオキサシリルスルフォニル
)−フェニル] 1.2.4−トリアジン−3゜5
(28,4H)−ジオン
式(II)で表される出発物質の製造例2−(4−ヒド
ロキシフェニル)−1,2,4−トリアジン−3,5(
2,4H)−ジオン式(V)で表される出発物質の製造
例
2−(4−ヒドロキシフェニル)−3,5(2H。Example 9 2-[4-(2'-benzoxasilylsulfonyl)-3,5-dichlorophenyl]l,2.4triazine-3,5(2H,4H)-dione 11)
-2-[4-(2'-benzoxasilylsulfonyl)-phenyl] 1.2.4-triazine-3゜5
(28,4H)-dione Preparation example 2 of starting material represented by formula (II) 2-(4-hydroxyphenyl)-1,2,4-triazine-3,5(
2,4H)-Dione Example of Preparation of Starting Material of Formula (V) 2-(4-Hydroxyphenyl)-3,5(2H.
4H)ジオキソ−1,2,4−トリアジン−6−カルボ
ン酸
34g (0,137モル)のカルボン酸を34mQの
メルカプト酢酸中170℃で加熱する。1゜5h後該混
合物を放冷し、水を添加し、該混合物を濾別し、24g
(理論値の82%)の脱カルボキシル化生成物を得る。4H) Dioxo-1,2,4-triazine-6-carboxylic acid 34 g (0,137 mol) of the carboxylic acid are heated at 170 DEG C. in 34 mQ of mercaptoacetic acid. After 1.5 hours, the mixture was allowed to cool, water was added, the mixture was filtered, and 24 g
(82% of theory) of the decarboxylated product is obtained.
30.1g (0,13モル)のシアノアザウラシルを
1000m12のHCQ/氷酢酸(I: l)中14時
間還流下撹拌する。該混合物を放冷し、そして濃縮し、
残渣に水を添加し、沈澱生成物を吸引下濾別する(I9
g、理論値の59%)。30.1 g (0.13 mol) of cyanoazuracil are stirred under reflux for 14 hours in 1000 ml of HCQ/glacial acetic acid (I:l). The mixture was allowed to cool and concentrated;
Water is added to the residue and the precipitated product is filtered off under suction (I9
g, 59% of theory).
式(Vl)で表される出発物質の製造例2−(4−ヒド
ロキシフェニル)−3,5−(2H,4H)ジオキソ−
6−ジアツー1.2.4−トリアジン
43.8g (0,158モル)のヒドラジノシアンウ
レタン(bydrazonocyanurethana
) 、8 。Production example of starting material represented by formula (Vl) 2-(4-hydroxyphenyl)-3,5-(2H,4H)dioxo-
43.8 g (0,158 mol) of 6-dia2-1,2,4-triazine
), 8.
5g(0,213モル)のNaOHを400mffの無
水エタノール中2時間還流する。引き続き該混合物を冷
却し、塩酸で酸性化し、真空下濃縮する。−槽を水と共
に撹拌し、沈澱生成物を吸引濾別する。乾燥後、30.
1g(理論値の85%)のシアノアザウラシルが得られ
る。5 g (0,213 mol) of NaOH are refluxed in 400 mff of absolute ethanol for 2 hours. The mixture is subsequently cooled, acidified with hydrochloric acid and concentrated under vacuum. - Stir the bath with water and filter off the precipitated product with suction. After drying, 30.
1 g (85% of theory) of cyanozauracil is obtained.
式(■)で表される出発物質の製造例
エチル−N−[[[シアノ(4−ヒドロキシフェニル)
−ヒドラジニリデン1−メチル]−カルボニル]−カー
バメート
10g(0,091モル)の4−ヒドロキシアニリンを
濃HC(I19,7mff及び氷酢酸200mQに溶解
し、該溶液に水30mQ中6.4g (0゜092モル
)亜硝酸ナトリウム溶液を0−5℃で滴下する。清澄溶
液が形成されるまで撹拌を続け、そして14.3g (
0,092モル)のシアノアセチルウレタンと21g(
0,25モル)の酢酸ナトリウムの混合物を添加し、1
0℃で3時間撹拌を続ける。反応混合物を真空下濃縮し
、水を添加し、固形物を吸引濾別する。かくして19g
(75%)の生成物が微結晶性黄色粉末として得られる
。Production example of starting material represented by formula (■) Ethyl-N-[[[cyano(4-hydroxyphenyl)
-Hydrazinylidene 1-methyl]-carbonyl]-carbamate 10 g (0,091 mol) of 4-hydroxyaniline are dissolved in concentrated HC (I19,7 mff) and 200 mQ of glacial acetic acid, and the solution is added to 6.4 g (0°) in 30 mQ of water. 092 mol) sodium nitrite solution is added dropwise at 0-5°C. Stirring is continued until a clear solution is formed and 14.3 g (
0,092 mol) of cyanoacetyl urethane and 21 g (
0.25 mol) of sodium acetate is added and 1
Continue stirring at 0°C for 3 hours. The reaction mixture is concentrated under vacuum, water is added and the solid is filtered off with suction. Thus 19g
(75%) of the product is obtained as a microcrystalline yellow powder.
本発明の好ましい実施態様としては、以下の如きものが
挙げられる。Preferred embodiments of the present invention include the following.
1、下記一般式(I)
式中、
R1は随時置換されていてもよい芳香族基、又は炭素原
子で結合している随時置換されていてもよい複素芳香族
基を表し;
N
Xはo、s、so、so、又は−CH−を表し;
R”は水1ハロゲン、ニトロ、アルキル、アルコキシ、
ハロゲノアルキル、ハロゲノアルコキシからなる群から
選ばれる、−又はそれ以上の、同−又は異なる基を表し
;
R3は水素、随時置換されたアルキル、アルケニル、ア
ルキニル、アラルキルを表すで表される置換1,2.4
−トリアジンジオン類、及びそれらの塩基による塩の魚
類寄生虫防除のための使用。1. The following general formula (I) In the formula, R1 represents an optionally substituted aromatic group or an optionally substituted heteroaromatic group bonded to a carbon atom; N X is o , s, so, so, or -CH-; R'' represents water, 1 halogen, nitro, alkyl, alkoxy,
Represents one or more same or different groups selected from the group consisting of halogenoalkyl and halogenoalkoxy; R3 represents hydrogen, optionally substituted alkyl, alkenyl, alkynyl, aralkyl; 2.4
- Use of triazinediones and their base salts for controlling fish parasites.
2、第1項による式(I)で表される1、2゜4−トリ
アジンジオンの少なくとも一つを含有することを特徴と
する、魚類寄生虫に対する薬剤。2. A drug against fish parasites, which contains at least one 1,2°4-triazinedione represented by formula (I) according to item 1.
3、第1項による式(I)で表されるl、2゜4−トリ
アジンジオンを魚類及び/又はそれらの棲息地に作用さ
せることを特徴とする魚類寄生虫防除のための1.2.
4−1−リアジンジオンの使用。3. 1.2. for controlling fish parasites, characterized in that l,2°4-triazinedione represented by formula (I) according to item 1 is applied to fish and/or their habitats.
Use of 4-1-riadinedione.
4、第1項による式(I)で表されるl、2゜4−トリ
アジンジオンを増量剤及び/又は界面活性剤と混合する
ことを特徴とする、魚類寄生虫に対する薬剤の製造方法
。4. A method for producing a drug against fish parasites, which comprises mixing l,2°4-triazinedione represented by formula (I) according to item 1 with a filler and/or a surfactant.
5、第1項による式(I)で表されるl、2゜4−トリ
アジンジオンの魚類寄生虫に対する薬剤の製造の為の利
用。5. Utilization of l,2°4-triazinedione represented by formula (I) according to item 1 for the production of a drug against fish parasites.
Claims (1)
原子で結合している随時置換され ていてもよい複素芳香族基を表し; XはO、S、SO、SO_2又は▲数式、化学式、表等
があります▼を 表し; R^2は水素、ハロゲン、ニトロ、アルキル、アルコキ
シ、ハロゲノアルキル、ハロゲノ アルコキシからなる群から選ばれる、一又 はそれ以上の、同一又は異なる基を表し; R^3は水素、随時置換されたアルキル、アルケニル、
アルキニル、アラルキルを表す で表される置換1,2,4−トリアジンジオン類、及び
それらの塩基による塩の魚類寄生虫防除のための使用。[Claims] 1. The following general formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) In the formula, R^1 is an aromatic group that may be optionally substituted, or a bond with a carbon atom represents an optionally substituted heteroaromatic group with Represents one or more same or different groups selected from the group consisting of alkyl, alkoxy, halogenoalkyl, and halogenoalkoxy; R^3 is hydrogen, optionally substituted alkyl, alkenyl,
Use of substituted 1,2,4-triazinediones represented by alkynyl, aralkyl, and their base salts for controlling fish parasites.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3826058A DE3826058A1 (en) | 1988-07-30 | 1988-07-30 | AGAINST FISH PARASITES |
DE3826058.1 | 1988-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02191216A true JPH02191216A (en) | 1990-07-27 |
Family
ID=6359988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1190712A Pending JPH02191216A (en) | 1988-07-30 | 1989-07-25 | Drug for fish parasite |
Country Status (14)
Country | Link |
---|---|
US (1) | US5464837A (en) |
EP (1) | EP0353526B1 (en) |
JP (1) | JPH02191216A (en) |
KR (1) | KR0137945B1 (en) |
AU (1) | AU620415B2 (en) |
CA (1) | CA1330296C (en) |
DE (2) | DE3826058A1 (en) |
DK (1) | DK374189A (en) |
ES (1) | ES2054940T3 (en) |
IE (1) | IE63034B1 (en) |
NO (1) | NO174232C (en) |
NZ (1) | NZ230105A (en) |
PH (1) | PH26132A (en) |
ZA (1) | ZA895762B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1044905A (en) * | 1989-02-16 | 1990-08-29 | 赫彻斯特股份公司 | Fish and entomophagous parasite worm antagonist |
DE4030042A1 (en) * | 1990-05-17 | 1991-11-21 | Bayer Ag | USE OF SUBSTITUTED 1,2,4-TRIAZINDIONES |
US5462938A (en) * | 1990-12-21 | 1995-10-31 | Annus; Gary D. | Arthropodicidal oxadiazinyl, thiadiazinyl and triazinyl carboxanilides |
US5747476A (en) * | 1996-07-17 | 1998-05-05 | Mortar & Pestle Veterinary Pharmacy, Inc. | Treatment of equine protozoal myeloencephalitis |
US5830893A (en) * | 1997-04-23 | 1998-11-03 | Mortar & Pestle Veterinary Pharmacy, Inc. | Treatment of equine protozoan myeloencephalitis using triazinediones |
CA2346463A1 (en) | 1998-10-08 | 2000-04-13 | New Ace Research Company | Use of sodium salts of triazine anticoccidial agents for the prevention and treatment of protozoal disease |
US6194408B1 (en) | 1998-12-22 | 2001-02-27 | Bayer Corporation | Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma |
DE19958388A1 (en) * | 1999-12-03 | 2001-06-07 | Bayer Ag | Triazinone compounds for the treatment of infestations with parasitic protozoa-related diseases |
US6429211B1 (en) | 2000-05-23 | 2002-08-06 | Bayer Corporation | Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora |
US7076292B2 (en) * | 2002-04-25 | 2006-07-11 | Medtronic, Inc. | Optical communication of neurostimulation-system information |
CN101563087B (en) * | 2006-06-27 | 2014-01-29 | 哈达斯特医疗研究服务和开发有限公司 | Use of stilbene derivatives for treatment and prevention of aquatic mold infections |
WO2009153758A2 (en) * | 2008-06-20 | 2009-12-23 | Ecolab Inc. | Insect bait station and method of using |
DE102009038950A1 (en) | 2009-08-26 | 2011-03-03 | Bayer Animal Health Gmbh | New antiparasitic combination of drugs |
DE102009038949A1 (en) | 2009-08-26 | 2011-03-03 | Bayer Animal Health Gmbh | New use of heterocyclic substituted 1,2,4-triazinediones |
CN103554046B (en) * | 2013-11-08 | 2015-04-01 | 中国农业科学院上海兽医研究所 | Chicken coccidiosis preventing triazine compound |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3912723A (en) * | 1971-03-29 | 1975-10-14 | Pfizer | 2-Phenyl-as-triazine-3,5(2H,4H)diones |
JPS54135264A (en) * | 1978-04-10 | 1979-10-20 | Ritsuo Shigeoka | Processing of fish meat |
US4284653A (en) * | 1979-01-13 | 1981-08-18 | Nippon Suisan Kabushiki Kaisha | Process for handling and processing fish meat |
DE3408924A1 (en) * | 1984-03-12 | 1985-09-26 | Hoechst Ag, 6230 Frankfurt | SUBSTITUTED 2-PHENYL-HEXAHYDRO-1,2,4-TRIAZINE-3,5-DIONE, METHOD FOR THE PRODUCTION THEREOF, MEANS CONTAINING IT AND THEIR USE |
BR8602556A (en) * | 1984-06-12 | 1987-02-03 | Fmc Corp | HERBICIDE COMPOUND; HERBICIDE COMPOSITION AND PROCESS TO CONTROL THE GROWTH OF UNWANTED PLANTS |
US4631278A (en) * | 1984-08-01 | 1986-12-23 | Janssen Pharmaceutica N.V. | Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor |
CA1244024A (en) * | 1984-08-01 | 1988-11-01 | Gustaaf M. Boeckx | .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES |
GB8602342D0 (en) * | 1986-01-30 | 1986-03-05 | Janssen Pharmaceutica Nv | 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones |
DE3805660A1 (en) * | 1988-02-24 | 1989-09-07 | Bayer Ag | SUBSTITUTED 1,2,4-TRIAZINDIONES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
US4933341A (en) * | 1988-10-08 | 1990-06-12 | Bayer Aktiengesellschaft | Substituted 1,3,5-triazinetriones, for use against parasitic protozoa |
DE3912100A1 (en) * | 1989-04-13 | 1990-10-25 | Bayer Ag | SUBSTITUTED URACILES, PROCESS FOR THEIR PREPARATION AND USE AGAINST PARASITOUS PROTOZOES |
-
1988
- 1988-07-30 DE DE3826058A patent/DE3826058A1/en not_active Withdrawn
-
1989
- 1989-06-30 AU AU37289/89A patent/AU620415B2/en not_active Ceased
- 1989-07-13 NO NO892891A patent/NO174232C/en unknown
- 1989-07-15 ES ES89113012T patent/ES2054940T3/en not_active Expired - Lifetime
- 1989-07-15 EP EP89113012A patent/EP0353526B1/en not_active Expired - Lifetime
- 1989-07-15 DE DE8989113012T patent/DE58904470D1/en not_active Expired - Fee Related
- 1989-07-25 JP JP1190712A patent/JPH02191216A/en active Pending
- 1989-07-27 NZ NZ230105A patent/NZ230105A/en unknown
- 1989-07-28 DK DK374189A patent/DK374189A/en not_active Application Discontinuation
- 1989-07-28 IE IE246789A patent/IE63034B1/en not_active IP Right Cessation
- 1989-07-28 ZA ZA895762A patent/ZA895762B/en unknown
- 1989-07-28 CA CA000606897A patent/CA1330296C/en not_active Expired - Fee Related
- 1989-07-29 KR KR1019890010796A patent/KR0137945B1/en not_active IP Right Cessation
- 1989-07-31 PH PH39027D patent/PH26132A/en unknown
-
1992
- 1992-07-13 US US07/913,758 patent/US5464837A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IE63034B1 (en) | 1995-03-22 |
ZA895762B (en) | 1990-04-25 |
EP0353526A3 (en) | 1991-11-27 |
NZ230105A (en) | 1991-04-26 |
NO174232C (en) | 1994-04-06 |
AU620415B2 (en) | 1992-02-20 |
CA1330296C (en) | 1994-06-21 |
KR0137945B1 (en) | 1998-04-30 |
AU3728989A (en) | 1990-02-01 |
PH26132A (en) | 1992-03-18 |
IE892467L (en) | 1990-01-30 |
EP0353526A2 (en) | 1990-02-07 |
DK374189D0 (en) | 1989-07-28 |
NO174232B (en) | 1993-12-27 |
NO892891L (en) | 1990-01-31 |
KR910002343A (en) | 1991-02-25 |
DE3826058A1 (en) | 1990-02-08 |
NO892891D0 (en) | 1989-07-13 |
US5464837A (en) | 1995-11-07 |
DE58904470D1 (en) | 1993-07-01 |
EP0353526B1 (en) | 1993-05-26 |
DK374189A (en) | 1990-01-31 |
ES2054940T3 (en) | 1994-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH02191216A (en) | Drug for fish parasite | |
JP2703607B2 (en) | Substituted 1,2,4-triazinediones, their preparation and use | |
AU634657B2 (en) | Use of substituted 1,2,4-triazinediones | |
US6294536B1 (en) | Triazine derivatives, their production and use | |
US5256631A (en) | Substituted 1,2,4-triazinediones, and their use | |
KR100346128B1 (en) | Triazine derivatives, their preparation methods and uses | |
US5114938A (en) | Parasiticidal substituted hexahydro-1,2,4-triazinediones and use thereas | |
JPH02164873A (en) | Substituted 1,3,5-triazinetrion, production thereof, and | |
JP2572795B2 (en) | Fish parasite control agent | |
US5985875A (en) | 1,2,4-triazine-3, 5-dione derivatives, their production and use thereof | |
NZ239788A (en) | 2-(4-substituted phenyl)-1,2,4-triazinedione derivatives and compositions for treating parasitic protozoa | |
US5214043A (en) | Parasiticidal substituted hexahydro-1,2,4-triazinediones | |
US5994355A (en) | 1, 2, 4-Triazin-3-one derivatives, production and use thereof | |
JPH02292265A (en) | Substituted uracil and preparation thereof | |
JPH10120662A (en) | 1,2,4-triazin-3,5-dione derivative and its use | |
JPH11152277A (en) | Triazine derivative, its production and use | |
JPH09124617A (en) | Triazine derivative and use thereof |